Aston Health has many years of experience in PATE and anticoagulant therapy research (specifically, the drugs that improve the heart’s function such as angioprotectors and microcirculation correctors).

The outcomes of Aston’s research in Cardiology provide a rationale for uptake of new effective health technologies at the regional and federal level.

In our studies we accumulate the cutting-edge knowledge and experience in CVD treatment obtained from various market stakeholders, including healthcare experts, clinicians and patient communities.

Elena Koshkarova

Elena Koshkarova

Head of Therapeutic Direction Rheumatology

Link to Related Sections